Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00679458 · ClinicalTrials.gov registry record · NA
Randomized, Double-Blind Cross-Over Trial Of Buprenorphine and Low-Dose Naloxone Versus Buprenorphine
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT00679458 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 12 participants.
The verdict
NCT00679458, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
This study compares two medications for analgesic potency and side effects in a sample of individuals with moderate pain. After screening, eligible participants will be randomly assigned to begin blinded treatment with one of two medications. Participants receive 5 daily doses of medication (no more than 2 days between each dose) followed by crossover to the opposite treatment condition for 5 additional daily doses. Each study day, participants will provide a daily pain assessment, receive administration of study medication, and will then be monitored and assessed for pain and side effects over 6 hours.
Interventions
- DRUG buprenorphine and low-dose naloxone
- DRUG buprenorphine alone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2008-09 |
| Est. Completion | 2009-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00679458
The ClinicalTrials.gov registry entry for NCT00679458 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which buprenorphine and low-dose naloxone is the first listed.
NCT00679458 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00679458 about?
NCT00679458 is a clinical study titled "Randomized, Double-Blind Cross-Over Trial Of Buprenorphine and Low-Dose Naloxone Versus Buprenorphine". This study compares two medications for analgesic potency and side effects in a sample of individuals with moderate pain. After screening, eligible participants will be randomly assigned to begin blinded treatment with one of two medications. Participants receive 5 daily doses of medication (no more...
What is the current status of trial NCT00679458?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2008-09. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00679458?
The interventions under investigation include: buprenorphine and low-dose naloxone (DRUG), buprenorphine alone (DRUG).
Who is sponsoring clinical trial NCT00679458?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.